Executive Profile*

Adrian Rawcliffe

AgeTotal Calculated CompensationThis person is connected to 57 board members in 5 different organizations across 6 different industries.

See Board Relationships


Mr. Adrian Rawcliffe, also known as Ad, has been the Chief Financial Officer of Adaptimmune Therapeutics plc since March 16, 2015 and serves as its Principal Accounting Officer. Mr. Rawcliffe leads financial strategy, management and operations functions including compliance and risk management. He served as the Chief Financial Officer of Human Genome Sciences Inc. since August 2012. He has 17 years of experience within the pharmaceutical industry and also served as ...

Read Full Background

Corporate Headquarters*

14200 Shady Grove Road
Rockville, Maryland 20850-7464

United States

Phone: 301-309-8504
Fax: 301-309-8512

Board Members Memberships*



Durham University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Unexercisable Options3,600,000
Total Number of Options3,600,000

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Randal J. Kirk J.D.Chairman and Chief Executive Officer
Intrexon Corporation
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.